Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lester Zambrana"'
Autor:
Matthew R. Cohn BS, Guang-Ting Cong BS, Benedict U. Nwachukwu MD, MBA, Minda L. Patt MD, Pingal Desai MD, Lester Zambrana BA, Joseph M. Lane MD
Publikováno v:
Geriatric Orthopaedic Surgery & Rehabilitation, Vol 7 (2016)
Background: Hip fractures are common in the elderly and are likely to become more prevalent as the US population ages. Early functional status is an indicator of longer term outcome, yet in-hospital predictors of functional recovery, particularly tim
Externí odkaz:
https://doaj.org/article/f582af06782b46e8a9d859e729ce0186
Publikováno v:
Journal of Orthopaedic Trauma. 30:1-9
OBJECTIVES Long bone fractures that fail to heal or show a delay in healing can lead to increased morbidity. Bone marrow aspirate concentrate (BMAC) containing bone mesenchymal stem cells (BMSCs) has been suggested as an autologous biologic adjunct t
Autor:
Lester Zambrana, Joseph M. Lane, Pingal Desai, Guang-Ting Cong, Minda L. Patt, Matthew R. Cohn, Benedict U. Nwachukwu
Publikováno v:
Geriatric Orthopaedic Surgery & Rehabilitation
Geriatric Orthopaedic Surgery & Rehabilitation, Vol 7 (2016)
Geriatric Orthopaedic Surgery & Rehabilitation, Vol 7 (2016)
Background: Hip fractures are common in the elderly and are likely to become more prevalent as the US population ages. Early functional status is an indicator of longer term outcome, yet in-hospital predictors of functional recovery, particularly tim
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 99(9)
To compare the effectiveness of high viscosity cement radiofrequency targeted vertebral augmentation (RF-TVA) and balloon kyphoplasty on spinal sagittal balance through radiologic evaluation.The present retrospective study included patients whom unde
Autor:
Ed Purdue, Athanos Karamitros, Joseph M. Lane, Jonathan E. Jo, Samir K. Trehan, Lester Zambrana, Joseph T. Nguyen
Publikováno v:
HSS Journal
Background Periprosthetic osteolysis (PPO) is a frequent indication for total hip replacement (THR) failure. Currently, PPO diagnosis occurs in advanced stages that often necessitate complex revisions due to bone loss. PPO biomarkers could facilitate
Autor:
Joaquin Moya-Angeler, Arianna L. Gianakos, Charles N. Cornell, Joseph M. Lane, Shivi Duggal, Kara G. Fields, Lester Zambrana, Douglas N. Mintz
Osteonecrosis of the femoral head (ONFH) is a devastating disease with complete collapse of the femoral head often reported in greater than 70% of patients within 3 to 4 years of diagnosis. Early intervention prior to collapse may improve the chance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447f7942a947b9bd069a003fbc5a0eb3
https://europepmc.org/articles/PMC4916091/
https://europepmc.org/articles/PMC4916091/
Publikováno v:
Orthopedics. 38
Platelet-rich plasma (PRP) has been suggested as an adjunct to aid in long-bone healing. The purpose of this study was to systematically review the basic science in vivo evidence for the use of PRP in the treatment of bone pathology. The PubMed/MEDLI
Publikováno v:
Hip international : the journal of clinical and experimental research on hip pathology and therapy. 26(2)
Introduction Atypical femoral fractures (AFF) can be present in patients with hip osteoarthritis (OA). This case highlights the opportunity to review the management of stress reactions, stress fractures and atypical femoral fractures, which depend on
Autor:
Anas Saleh, Pingal Desai, Vishal Hegde, Lester Zambrana, Saad Mumtaz Hasan, Joseph M. Lane, Matthew R. Cohn
Publikováno v:
HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 11(2)
While the gold standard of treatment of nonunion is open autologous bone grafting, studies have shown that injecting bone marrow aspirate concentrates (BMAC) is effective in treating tibial nonunions with fracture gaps less than 5 mm.We aim to demons
Autor:
Hana Totary-Jain, Lester Zambrana, Cula N. Dautriche, Despina Sanoudou, Andrew R. Marks, Hillary Schneller
Publikováno v:
Cancer research. 72(7)
The mammalian target of rapamycin (mTOR) plays a role in controlling malignant cellular growth. mTOR inhibitors, including rapamycin (sirolimus), are currently being evaluated in cancer trials. However, a significant number of tumors are rapamycin re